Morgan Stanley analyst Ricky Goldwasser maintained a Sell rating on Walgreens Boots Alliance (WBA – Research Report) today and set a price target of $39.00. The company’s shares closed last Wednesday at $37.89, close to its 52-week low of $36.98.
According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 12.8% and a 62.9% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Alignment Healthcare, and AmerisourceBergen.
Walgreens Boots Alliance has an analyst consensus of Hold, with a price target consensus of $44.82.
The company has a one-year high of $55.00 and a one-year low of $36.98. Currently, Walgreens Boots Alliance has an average volume of 7.01M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
Read More on WBA: